Galicia
Biodays
Program

2024

8:00 – 8:45

Credential Pickup 🎫

Main Hall

8:45 – 9:00

Hello Galicia Biiodays!

Main Hall

  • Julio Martínez, Project Manager at BIOGA

9:00 – 9:30

Evolution of drug discovery research and the role of new technologies

Main Hall

  • Yves P. Auberson, Executive Director Global Discovery Chemistry at Novartis Institutes for Biomedical Research & Vice President of the Swiss Chemical Society
novartis

9:30 – 10:15

Galicia Biodays 2024 Inauguration

Main Hall

  • José Manuel López Vilariño, Bioga President
  • Carmen Cotelo, Director of Axencia Galega de Innovación
  • David Regades, State Delegate in the Vigo Free Trade Zone Consortium (CZFV)
  • Teresa Riesgo, Secretary General for Innovation, Ministry of Science, Innovation and Universities
  • Abel Caballero, Mayor of Vigo

10:15 – 11:00

The Impact of Biotechnology Strategies on Regions

Main Hall

  • Christian Suojanen, CEO of Broadreach Global and Member of the Board of Directors of the European Brain Foundation
  • Giuseppina Luvarà, Policy Officer Bioeconomy and Food Systems, Directorate-General for Research and Innovation, DG RTD

Moderated by: Carmen Cotelo, Director of the Galician Innovation Agency

11:00 – 11:30

Coffee Break ☕️

Main Hall

LONZA

11:30 – 12:00

Engineering a life therapeutic for lung diseases; from bench to company

Main Hall

  • Luis Serrano Pubul, Director of the Centre for Genomic Regulation (CRG)

12:00 – 12:30

AI (r?)evolution. Have we learned from past waves of (r?)evolutionary technologies?

Main Hall

  • Robert Soliva, Principal Data Scientist at Almirall

12:30 – 13:30

The power of technology in the search for new drugs

Main Hall

  • Jordi Mestres, CSO at Chemotargets
  • Olga Genilloud, Scientific Director at Fundación Medina
  • László Kiss, Senior Manager, Medicinal Chemistry at BIAL
  • Juan José Carrillo, Director of the Department of Biophysics and Pharmacology at Lilly Spain

Moderated by: Iván Marcos, Pharma/Biotech Strategic Collaborations Manager at Promega

Promega Logo

13:30 – 14:30

Biotechnological challenges in cosmetics innovation for well-being

Main Hall

  • Thalía González, Cosmetic Innovation Manager at Cantabria Labs
  • Ana Torrejón, Head of Microbiology and Industrial Biotechnology at AINIA
  • Cristóbal Bernal, Director Técnico en Grupo Carinsa
  • Mónica Buendía, Expert in Cosmetic Product Development

Moderated by: Ariana Fernández, President of the Galician Cosmetics Association

14:30 – 16:00

Break 🍽️

Main Hall

16:00 – 16:30

The Potential of Omics in the Food Industry

Main Hall

  • José Manuel López Vilariño, Director of R&D at Hijos de Rivera

16:30 – 17:30

Food innovation: Changes transforming our table

Main Hall

  • Joaquín del Río, R&D and Director of Quality
  • Nuria Morales, Co-Founder at Komvida Organic Kombucha
  • José Manuel López Vilariño, R&D Director at Hijos de Rivera
  • Begoña Pérez-Villareal, Director of EIT Food South

Moderated by: Paula Álvarez, Technical Sales Manager, AIT Ingredients

8:00 – 9:00

Credential Pickup

BioTalent

11:00 – 11:30

Coffee Break ☕️

Main Hall

LONZA

11:30 – 12:00

What bio companies are looking for in talent?

BioTalent

  • Carme Pampín, Vice President of Bioga
  • María Seoane, CEO of BFlow
  • Alberto Fernández, CEO of Servitalent

12:00 – 12:15

Presentation of the Master in Management of Biotechnology Companies (MBIO)

BioTalent

  • Julio Martínez, Project Manager at BIOGA

12:15 – 14:30

BioTalent Day

BioTalent

A dynamic event, an experience, and a talent competition that connects junior and senior profiles with Galician biotechnological companies.

  • BIOGA, Mateo Tuñón Granda, Project Manager
  • GalChimia, Antía Blanco, CHRO/Human Resources Manager
  • AMSlab, David Seijas Vázquez, Human Resources Health & Safety Manager
  • Lonza, Rocío Piñeiro, HR Business Partner
  • CETIM, Vanessa Fernández, People & Talent Manager
  • ANFACO-CECOPESCA, Sonia Corada, Human Resources and Labour Relations Manager
  • Granja Campomayor, Human Capital Coordinator
  • Biopranaworld, Jesús González, Head of R+D+i Laboratory
  • Mestrelab Research, Esperanza Pereira, Legal Advisor & Human Resources
  • ZENDAL, Cecilia Mariño, Human Resources Director
  • CEAMSA, Katherine Vázquez, Human Reources Manager

14:30 – 16:00

Break 🍽️

BioTalent

16:00 – 17:00

Transparency, confidentiality and strategy: The challenge of communicating in the biotech sector

BioTalent

  • Beatriz Díaz Lorenzo, Director of Communications & Global Brand at ZENDAL
  • Verónica Fuentes, Head of the Health Section at SINC
  • Pablo López, Director of GCiencia
  • Noel Queipo, Comunication Manager at CINBIO

Moderated by: Beatriz González Amandi, Journalist specialising in Institutional and Scientific Communication at Effectia

17:00 – 18:00

Round table: Connecting Bioregions – Perspectives on Biotechnology and Internationalisation

BioTalent

  • Japan: Lauren Ha, Associate Vice President de Okinawa Institute of Science and Technology (OIST)
  • Italy: Mariangela Squarciafico, Junior Business Development e Innovation Manager en Piemonte Health Innovation Cluster (bioPmed) and Bioindustry Park Silvano Fumero
  • Belgium: Florence Vanholsbeeck, Economic and Trade Counselor en Wallonia Export & Investment Agency (AWEX)
  • India: Garima Arora, Representative of the Spanish-India Chamber of Commerce

Moderated by: Daniel Álvarez, Project Manager at Bioga

8:00 – 9:00

Credential Pickup

BioInvestor

11:00 – 11:30

Coffee Break ☕️

Main Hall

LONZA

11:30 – 12:15

The current investment landscape in the biotech sector

BioInvestor

  • Santi Domínguez, Bioga’s Board of Directors
  • Pablo Álvarez, President of DATAlife
  • Alex Marín, Managing partner at Inventium
  • Yolanda Falcón, Director of Investee Management at XesGalicia

12:15 – 14:30

BioInvestor Day

BioInvestor

Investment forum that connects life sciences projects and companies with national and international investors.
  • Néboda Farms, Samuel López Novoa, Head of R&D
  • GLA up, Saida Ortolano, Principal Investigator
  • Perfect Numbers, Gonzalo Abuín Pérez, CEO
  • Molefy, Sara Vidal, Co-founder & Head of Biotechnology
  • Galinsect, María Febrero, Executive Director
  • RESOLVA, Ismael Bermejo, CEO
  • Arenamar, Bárbara Álvarez Besadío, Head of R&D
  • Nucaps, Mariano Oto, CEO
  • Celia, Daniel Rodríguez Silva, CTO
  • ODS Protein, Iria Varela, CEO
  • ENZICAS, Victor Lama González, Partner
  • MicroMarkers, Juan Vallejo, Researcher

14:30 – 16:30

Break 🍽️

16:00 – 17:00

Funding mechanisms and strategies in the transfer of the biotech sector

BioInvestor

  • Roberto Ranera, General Partner at Beable Capital
  • Victor Gonzalez, R&D Director at Atrys
  • Eduardo Pérez, Analyst in Tech Transfer Agrifood/Clave
  • María Seoane, CEO of BFlow

Moderated by: Luis Otero, Knowledge Transfer Delegate of USC

17:00 – 17:20

CinfaNext Presentation

BioInvestor

  • Marta Pedrosa, Innovation Analyst at CINFA

CinfaNext is Cinfa’s new Open Innovation Platform, which aims to identify new trends and innovative projects that respond to people’s health needs through new collaborative forms of innovation.

17:20 – 17:40

Presentation of Converge, the CSIC’s open innovation hub and its CSIC COCREA programme

BioInvestor

  • Ana Sanz, Head of the Coordination Unit for initiatives associated with the Open Innovation Hub – Converge. Vice-Presidency for Innovation and Transfer, CSIC

Programme to promote collaborative projects between the CSIC and companies based on a two-way exchange of knowledge and the development of solutions around a challenge from the conception of the idea to the market. It is aimed at CSIC researchers and companies at a global level.

17:40 – 18:00

Presentation of Faes Ventures

BioInvestor

  • Ignacio Sancho Martínez, Director of the Drug Discovery Department at Faes Farma

FAES Farma is a pharmaceutical company with more than 90 years of experience in the research, production and marketing of pharmaceutical products worldwide. FAES Farma has created a unit dedicated to the search and evaluation of investment opportunities, with the aim of significantly expanding its Drug Discovery portfolio, contributing to our goal of improving patients’ health by manufacturing new innovative pharmaceutical solutions.